{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:29:47Z","timestamp":1772605787020,"version":"3.50.1"},"reference-count":55,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates often found in chronic inflammatory conditions, including cancer. These structures, which share many cellular and functional features with secondary lymphoid organs, can profoundly influence the tumor microenvironment by promoting local anti-tumor immune activation. TLSs have been observed in various cancers, including melanoma, and are associated with improved responses to immunotherapy and clinical outcomes. However, our understanding of the molecular mechanisms underlying TLS formation and function remains incomplete. This review summarizes the current findings on TLSs in human melanoma, drawing from multiple studies to provide an updated overview. We discuss the cellular composition, spatial distribution, and genetic signatures of TLSs at different stages of melanoma pathogenesis and in subtypes including acral, uveal, and desmoplastic melanoma. Additionally, we examine the influence of tumor mutational burden (TMB) and complement activation on TLS formation, as well as the role of TLSs in immune checkpoint inhibitor therapy. We also highlight the potential of TLSs as indicators for disease progression and treatment response, and review preclinical strategies aimed at inducing TLSs to improve therapeutic outcomes. This synthesis aims to support ongoing research into the role of TLSs in melanoma immunobiology.<\/jats:p>","DOI":"10.3390\/cells14171378","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T10:55:37Z","timestamp":1756983337000},"page":"1378","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tertiary Lymphoid Structures in Human Melanoma: Molecular Mechanisms and Therapeutic Opportunities"],"prefix":"10.3390","volume":"14","author":[{"given":"Gelare","family":"Ghajar-Rahimi","sequence":"first","affiliation":[{"name":"Department of Dermatology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3229-611X","authenticated-orcid":false,"given":"Ishika","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5730-0037","authenticated-orcid":false,"given":"Nabiha","family":"Yusuf","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1600-6143.2004.00714.x","article-title":"Lymphoid Neogenesis in Murine Cardiac Allografts Undergoing Chronic Rejection","volume":"5","author":"Baddoura","year":"2005","journal-title":"Am. J. Transplant."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri3700","article-title":"Ectopic lymphoid-like structures in infection, cancer and autoimmunity","volume":"14","author":"Pitzalis","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2007.15.0284","article-title":"Long-Term Survival for Patients with Non\u2013Small-Cell Lung Cancer with Intratumoral Lymphoid Structures","volume":"26","author":"Antoine","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ajpath.2011.03.007","article-title":"Unique Ectopic Lymph Node-Like Structures Present in Human Primary Colorectal Carcinoma Are Identified by Immune Gene Array Profiling","volume":"179","author":"Coppola","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00262-019-02407-8","article-title":"The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer","volume":"68","author":"Sofopoulos","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1158\/1078-0432.CCR-15-2762","article-title":"Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer","volume":"22","author":"Kroeger","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-23355-x","article-title":"B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma","volume":"12","author":"Ruffin","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1158\/0008-5472.CAN-12-1377","article-title":"Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases","volume":"72","author":"Cipponi","year":"2012","journal-title":"Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nature11624","article-title":"An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair\/fair skin background","volume":"491","author":"Mitra","year":"2012","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R","article-title":"Melanoma and sun exposure: An overview of published studies","volume":"73","author":"Elwood","year":"1997","journal-title":"Int. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1001\/jama.1987.03400210088032","article-title":"Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals","volume":"258","author":"Rhodes","year":"1987","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Djavid, A.R., Stonesifer, C., Fullerton, B.T., Wang, S.W., Tartaro, M.A., Kwinta, B.D., Grimes, J.M., Geskin, L.J., and Saenger, Y.M. (2021). Etiologies of Melanoma Development and Prevention Measures: A Review of the Current Evidence. Cancers, 13.","DOI":"10.3390\/cancers13194914"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.critrevonc.2016.04.010","article-title":"Malignant melanoma\u2014The cradle of anti-neoplastic immunotherapy","volume":"106","author":"Koller","year":"2016","journal-title":"Crit. Rev. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.det.2025.03.005","article-title":"Trends in Melanoma Incidence and Mortality","volume":"43","author":"Shah","year":"2025","journal-title":"Dermatol. Clin."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41590-022-01141-1","article-title":"A decade of checkpoint blockade immunotherapy in melanoma: Understanding the molecular basis for immune sensitivity and resistance","volume":"23","author":"Huang","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Maibach, F., Sadozai, H., Jafari, S.M.S., Hunger, R.E., and Schenk, M. (2020). Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.02105"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Werner, F., Wagner, C., Simon, M., Glatz, K., Mertz, K.D., L\u00e4ubli, H., Griss, J., and Wagner, S.N. (2021). A Standardized Analysis of Tertiary Lymphoid Structures in Human Melanoma: Disease Progression- and Tumor Site-Associated Changes with Germinal Center Alteration. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.675146"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Femel, J., Hill, C., Bochaca, I.I., Booth, J.L., Asnaashari, T.G., Steele, M.M., Moshiri, A.S., Do, H., Zhong, J., and Osman, I. (2024). Quantitative multiplex immunohistochemistry reveals inter-patient lymphovascular and immune heterogeneity in primary cutaneous melanoma. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1328602"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/978-1-0716-1205-7_40","article-title":"Multiplex Immunofluorescence Histology for Immune Cell Infiltrates in Melanoma-Associated Tertiary Lymphoid Structures","volume":"2265","author":"Mauldin","year":"2021","journal-title":"Methods Mol Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e009231","DOI":"10.1136\/jitc-2024-009231","article-title":"Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas","volume":"12","author":"Karapetyan","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kazanietz, M.G., Durando, M., and Cooke, M. (2019). CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00471"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Messina, J.L., Fenstermacher, D.A., Eschrich, S., Qu, X., Berglund, A.E., Lloyd, M.C., Schell, M.J., Sondak, V.K., Weber, J.S., and Mul\u00e9, J.J. (2012). 12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?. Sci. Rep., 2.","DOI":"10.1038\/srep00765"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cell.2022.12.028","article-title":"Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer","volume":"186","author":"Lin","year":"2023","journal-title":"Cell"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Munoz-Erazo, L., Park, S.M., Lin, S., Chen, C.-J.J., Zhou, L.Y.Y., Rhodes, J.L., Jeon, T., Fenton, S., McCall, J.L., and Kemp, R.A. (2025). A novel approach to digital characterisation of Tertiary Lymphoid Structures in colorectal cancer. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1500792"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"23097","DOI":"10.1038\/s41598-023-50327-6","article-title":"The molecular subtypes and clinical prognosis characteristic of tertiary lymphoid structures-related gene of cutaneous melanoma","volume":"13","author":"Li","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/pcmr.12459","article-title":"The genomic landscape of cutaneous melanoma","volume":"29","author":"Zhang","year":"2016","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Salem, D., Chelvanambi, M., Storkus, W.J., and Fecek, R.J. (2021). Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.629519"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zhang, G., Li, S., Xiao, W., Zhang, C., Li, T., Liao, Z., Liu, H., Xing, R., Yao, W., and Yang, J. (2024). Tumoral C2 Regulates the Tumor Microenvironment by Increasing the Ratio of M1\/M2 Macrophages and Tertiary Lymphoid Structures to Improve Prognosis in Melanoma. Cancers, 16.","DOI":"10.3390\/cancers16050908"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e002273","DOI":"10.1136\/jitc-2020-002273","article-title":"Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma","volume":"9","author":"Lynch","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/CCO.0000000000001015","article-title":"Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?","volume":"36","author":"Padonou","year":"2024","journal-title":"Curr. Opin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature25187","article-title":"High response rate to PD-1 blockade in desmoplastic melanomas","volume":"553","author":"Eroglu","year":"2018","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1158\/2767-9764.CRC-22-0490","article-title":"Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy","volume":"3","author":"Sah","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"ref_37","first-page":"1","article-title":"Tertiary lymphoid structures associated with improved survival and enhanced antitumor immunity in acral melanoma","volume":"9","author":"Su","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41590-021-00958-6","article-title":"Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy","volume":"22","author":"Eschweiler","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/ni.3578","article-title":"Suppression by TFR cells leads to durable and selective inhibition of B cell effector function","volume":"17","author":"Sage","year":"2016","journal-title":"Nat. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm.2425","article-title":"Foxp3+ follicular regulatory T cells control the germinal center response","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade","volume":"175","author":"Shah","year":"2018","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma","volume":"175","author":"Yizhak","year":"2018","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","article-title":"Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma","volume":"176","author":"Li","year":"2018","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"110973","DOI":"10.1016\/j.intimp.2023.110973","article-title":"Association of NRAS mutations and tertiary lymphoid structure formation with clinical outcomes of adjuvant PD-1 inhibitors for acral melanoma","volume":"124","author":"Mo","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaad.2012.10.041","article-title":"Desmoplastic melanoma: A review","volume":"68","author":"Chen","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/CMR.0000000000000439","article-title":"Lymphoid aggregates in desmoplastic melanoma have features of tertiary lymphoid structures","volume":"28","author":"Stowman","year":"2018","journal-title":"Melanoma Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2164476","DOI":"10.1080\/2162402X.2022.2164476","article-title":"Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas","volume":"12","author":"Edmonds","year":"2023","journal-title":"OncoImmunology"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zhu, G., Nemoto, S., Mailloux, A.W., Perez-Villarroel, P., Nakagawa, R., Falahat, R., Berglund, A.E., and Mul\u00e9, J.J. (2018). Induction of Tertiary Lymphoid Structures with Antitumor Function by a Lymph Node-Derived Stromal Cell Line. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01609"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e001906","DOI":"10.1136\/jitc-2020-001906","article-title":"STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment","volume":"9","author":"Chelvanambi","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2093054","DOI":"10.1080\/2162402X.2022.2093054","article-title":"Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activation","volume":"11","author":"He","year":"2022","journal-title":"OncoImmunology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/cas.70105","article-title":"CXCL13 and CCL21 Induce Tertiary Lymphoid Structures and Enhance the Efficacy of Immunotherapy for Melanoma","volume":"116","author":"Yoshimitsu","year":"2025","journal-title":"Cancer Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.8171322","article-title":"Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in Lymphotoxin","volume":"264","author":"Goellner","year":"1994","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.4049\/jimmunol.161.12.6853","article-title":"Lymphotoxin \u03b13 Induces Chemokines and Adhesion Molecules: Insight into the Role of LT\u03b1 in Inflammation and Lymphoid Organ Development","volume":"161","author":"Cuff","year":"1998","journal-title":"J. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02786481","article-title":"Lymphoid neoorganogenesis","volume":"19","author":"Ruddle","year":"1999","journal-title":"Immunol. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1074-7613(01)00094-2","article-title":"Targeting of Lymphotoxin-\u03b1 to the Tumor Elicits an Efficient Immune Response Associated with Induction of Peripheral Lymphoid-like Tissue","volume":"14","author":"Schrama","year":"2001","journal-title":"Immunity"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/17\/1378\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:39:20Z","timestamp":1760035160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/17\/1378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":55,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cells14171378"],"URL":"https:\/\/doi.org\/10.3390\/cells14171378","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]}}}